[DISCLOSURE] HanALL BioPharma (009420) reported on Aug. 10 that its common stocks, safeguarded due to capital increase with third party allotment since Aug. 17, 2015, are set to be released on Aug. 16. Daewoong Pharmaceutical (069620) owns 9.5 million of these safeguarded shares.